DAFNA Capital Management LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,117,000
+56.1%
119,6150.0%2.80%
+47.9%
Q3 2021$7,123,000
-12.7%
119,6150.0%1.89%
+10.8%
Q2 2021$8,158,000
+53.3%
119,615
+55.9%
1.71%
+35.1%
Q1 2021$5,323,000
-9.8%
76,715
-0.1%
1.26%
-28.1%
Q4 2020$5,902,000
+4.1%
76,815
+1.3%
1.76%
-4.7%
Q3 2020$5,670,000
-63.3%
75,815
-69.1%
1.84%
-58.6%
Q2 2020$15,432,000
+104.5%
245,142
+36.5%
4.45%
+41.4%
Q1 2020$7,545,000
+67.9%
179,642
+81.6%
3.15%
+104.1%
Q4 2019$4,494,000
+4.5%
98,942
+5.3%
1.54%
-4.6%
Q3 2019$4,300,000
-21.9%
93,9420.0%1.62%
-21.9%
Q2 2019$5,508,000
+30.8%
93,9420.0%2.07%
+13.9%
Q1 2019$4,211,000
+15.1%
93,9420.0%1.82%
-0.2%
Q4 2018$3,659,000
-19.3%
93,942
-4.7%
1.82%
-2.3%
Q3 2018$4,535,000
+9.2%
98,547
+3.5%
1.86%
-4.2%
Q2 2018$4,153,000
-17.0%
95,242
-24.9%
1.94%
-20.2%
Q1 2018$5,006,000
+1810.7%
126,742
+715.1%
2.44%
+1202.1%
Q2 2017$262,00015,5500.19%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders